Abstract:OBJECTIVE:To study the effects of fusion gene encoding the hVEGF(165) and fused hirudin on restenosis of injured carotid artery.METHODS:A fusion gene encoding hVEGF(165) and fused hirudin (hVEGF(165)-FH) was constructed and clone into the eukaryotic expression vector pcDNA3.0, thus constructing the plasmid VEGF(165)-FH/pcDNA3.0. Its activities to stimulate endothelial cell proliferation and to inhibit thrombosis were identified. Sixteen New Zealand rabbits underwent ligation of external carotid artery and a balloon was inserted into the common carotid artery for 30 minutes so as to construct model of restenosis of injured carotid artery. Then the rabbits were randomly divided into 4 equal groups. In the one-week and 3-week control groups, 400 microg of DNA of the plasmid pcDNA3.0 were transfused into the arterial lumen at the injured part immediately after the angioplasty, and 400 microg of DNA of the plasmid VEGF(165)-FH/pcDNA3.0 were transfused in the 1-week and 3-week experimental groups. One week and 3 weeks after the treatment peripheral blood samples were collected to detect the activated partial thromboplastin time (APTT), thrombin time (TT), and platelet aggregation rate, and then the rabbits underwent angiography to observe the situation of restenosis. Then the rabbits were killed to take out the injured part of artery to undergo pathological examination and Western blotting.RESULTS:The values of APTT, TT, and platelet aggregation rate were not significantly different among the 4 groups. Angiography conducted 1 and 3 weeks later showed that restenosis was significantly mild in the 2 experimental groups in comparison with the 2 control groups, and severe restenosis was seen in the 3-week control group. Western blotting showed that expression of specific fused protein could be found in the 1-week and 3-week experimental group, the amount of the latter group being less than that of the former group; however, no expression of specific fused protein was found in the 2 control groups. Pathological examination showed that the narrowing of lumen 1-week and 3-week experimental groups were 11.50% and 19.75%, both significantly milder than those of the 1-week and 3-week control groups (33.25% and 52.25% respectively, both f P < 0.05). VB staining showed that the (intima/media (I/M) ratio of the 1-week and 3-week experimental groups were 0.12 and 0.35 respectively, both significantly lower than those of the 2 control groups (0.50 and 1.07 respectively, both P < 0.05).CONCLUSION:Accelerating re-endothelialization and inhibiting thrombosis, the fused gene hVEGF(165)-FH effectively prevents restenosis after angioplasty, On the basis of endothelial repair, construction of fused genes with double even multiple targets may be a novel and potential therapeutic approach for restenosis after percutaneous coronary intervention.

Gene therapy with human vascular endothelial growth factor in prevention of restenosis after angioplasty

[Effects of Fusion Gene Encoding the Hvegf165 and Fused Hirudin on Restenosis of Injured Carotid Artery Induced by Angioplasty].

Effect of Co-Transfection of VEGF and PCNA-ASODN on Restenosis after Percutaneous Transluminal Coronary Angioplasty

[To Study the Effects of Local Co-Transfection Vascular Endothelial Growth Factor165 and Tissue-Type Plasminogen Activator Genes on Inhibiting Intimal Hyperplasia after Operation Injury Artery in Rabbits].

Inhibitory effects of local transfection of vascular endothelial growth factor 165 gene on intimal hyperplasia of artery in rabbits after operation injury

Intravascular Magnetic Resonance/radiofrequency May Enhance Gene Therapy for Prevention of In-Stent Neointimal Hyperplasia.

Adenovirus-mediated Hypertension-Related Gene Transfer to Rabbit Carotid Ateries Inhibits Neointimal Formation after Balloon Angioplasty

Angiogenesis Effect on Rat Liver after Administration of Expression Vector Encoding Vascular Endothelial Growth Factor D

Raav-Mediated VEGF Gene Transfer Induces Neovascular Formation in a Rabbit Myocardial Ischemic Model

Experimental Research on Atrovastatin in Prevention of Restenosis of Rat Carotis and Correlation of Serum VEGF

The Therapeutic Effect of Vascular Endothelial Growth Factor Gene- or Heme Oxygenase-1 Gene-Modified Endothelial Progenitor Cells on Neovascularization of Rat Hindlimb Ischemia Model.

[Effect of Nanoparticle with Vascular Endothelial Growth Factor Gene Transferred into Ischemic Myocardium: Experiment with Rabbits].

Effects of Combined Angiopoietin-1 and Vascular Endothelial Growth Factor Gene Transfer on Neovascular Permeability of Rat Hindlimb Ischemia

Re-Endothelialization Study On Endovascular Stents Seeded By Endothelial Cells Through Up- Or Downregulation Of Vegf

Intramyocardial Injection of Vascular Endothelial Growth Factor Gene Improves Cardiac Performance and Inhibits Cardiomyocyte Apoptosis.

Effects of Human Growth Arrest-Specific Homeobox Gene Delivery on Proliferation, Migration and Cell Cycle Distribution of Vascular Smooth Muscle Cells

Retroviral vector mediated vascular endothelial growth factor gene therapy for experimental rabbits with cerebral ischemia

A Preliminary Study of the Therapeutic Role of Human Early Fetal Aorta-derived Endothelial Progenitor Cells in Inhibiting Carotid Artery Neointimal Hyperplasia.

A Double-Injury Model of Rabbit Carotid Artery for the Understanding of Restenosis After Experimental Angioplasty

Study on Restoration of Bfgf Gene for Rabbit Internal Carotid Artery Aneurysm Wall

Effects of Human Wild-Type P53, Rb, Antisense Human IGF-I and Antisense Rat AT1B Gene Transfer on Neointimal Proliferation after Carotid Artery Injury in Rat